|
End-of-day quote
Korea S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 13,900.00 KRW | +8.76% |
|
-6.52% | -28.90% |
| 09-20 | Onconic Therapeutics Inc.(KOSDAQ:A476060) added to S&P Global BMI Index | CI |
| 25-10-30 | Onconic Therapeutics Q3 operating profit 8.3 billion won, swings to profit from year earlier | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 432M | - | - | - | - | - |
| 68.98B | |||||
| 53.15B | |||||
| 50.83B | |||||
| 44.61B | |||||
| 42.53B |
Select your edition
All financial news and data tailored to specific country editions
